Skin & Hair

Copper-binding tripeptide with broad effects on wound healing, collagen synthesis, and hair follicle function.

Copper tripeptide used topically to stimulate hair follicle activity and improve follicle vascularization.

Oral capsule form of GHK-Cu marketed for systemic skin and connective tissue support.

Proprietary compounded blend combining GHK-Cu, BPC-157, and TB-500 for skin and systemic regeneration.

Compounded extension of GLOW that adds KPV to BPC-157, TB-500, and GHK-Cu for broad repair and anti-inflammatory effects.

Topical peptide marketed as a 'Botox-like' muscle relaxant by modulating SNARE-complex assembly, reducing expression lines.

Synthetic α-MSH analog producing tanning and libido effects; non-selective melanocortin agonist.

The core GHK tripeptide without bound copper; lower potency than GHK-Cu but simpler formulation.

Lipidated procollagen-I fragment that feedback-stimulates fibroblast collagen/fibronectin synthesis. Reduces wrinkle depth in blinded trials.

Synthetic α-MSH analog that selectively activates MC1R to stimulate melanogenesis without the broad melanocortin side effects of Melanotan II. The only FDA-approved melanocortin peptide for a dermatological indication (Scenesse, 2019, for erythropoietic protoporphyria).

A pair of lipidated signal peptides used in premium anti-aging skincare. Pal-Tripeptide-1 (Pal-GHK) stimulates collagen synthesis via the matrikine pathway; Pal-Tetrapeptide-7 (Pal-GQPR) reduces inflammation by inhibiting IL-6 release. Sold together as 'Haloxyl' for under-eye applications.

Enzymatically hydrolyzed collagen (2–20 kDa) from bovine, marine, or porcine sources. The most widely consumed peptide product globally, with a growing evidence base for skin elasticity, joint health, and bone density. Distinct from injectable therapeutic peptides; this is an oral supplement category.